CA3291674A1 - Transglutaminases et leurs utilisations - Google Patents

Transglutaminases et leurs utilisations

Info

Publication number
CA3291674A1
CA3291674A1 CA3291674A CA3291674A CA3291674A1 CA 3291674 A1 CA3291674 A1 CA 3291674A1 CA 3291674 A CA3291674 A CA 3291674A CA 3291674 A CA3291674 A CA 3291674A CA 3291674 A1 CA3291674 A1 CA 3291674A1
Authority
CA
Canada
Prior art keywords
transglutaminases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3291674A
Other languages
English (en)
Inventor
Will Shindel
Robert DiCosimo
Erika M. Milczek
Ryan Woodyer
Marley ADAMEK
Jaina Ashwinkumar BHAYANI
John McArthur
Christian Kasey
Original Assignee
Curie Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curie Co Inc filed Critical Curie Co Inc
Publication of CA3291674A1 publication Critical patent/CA3291674A1/fr
Pending legal-status Critical Current

Links

CA3291674A 2023-05-19 2024-05-17 Transglutaminases et leurs utilisations Pending CA3291674A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/503,288 2023-05-19
US63/579,201 2023-08-28

Publications (1)

Publication Number Publication Date
CA3291674A1 true CA3291674A1 (fr) 2024-11-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP4096651A4 (fr) Composés et leurs utilisations
EP4096664A4 (fr) Composés et leurs utilisations
EP4096668A4 (fr) Composés et leurs utilisations
EP4247815A4 (fr) Composés et leurs utilisations
EP4165049A4 (fr) Psychoplastogènes d'isotryptamine et leurs utilisations
EP4337211A4 (fr) Composés et leurs utilisations
CA3291674A1 (fr) Transglutaminases et leurs utilisations
EP4330228A4 (fr) Inhibiteurs de g-alpha-s et leurs utilisations
CA3276902A1 (fr) Trianglamine substituée et ses utilisations
AU2023901461A0 (en) AIPROPERTY and AIREALESTATE
HK40108849A (en) Nitrophenyl-acrylamides and uses thereof
CA3301202A1 (fr) Composés et utilisations
CA3278890A1 (fr) Pyrroloquinazolinones spirocycliques et pipéridinoquinazolinones spirocycliques substituées
CA3307870A1 (fr) Composés et leurs utilisations
AU2024357784A1 (en) Compounds and uses thereof
CA3291811A1 (fr) Composés et leurs utilisations
AU2023902115A0 (en) Compounds and Uses Therefor
AU2023902113A0 (en) Compounds and uses therefor
AU2023901760A0 (en) Compounds and uses therefor
CA3270830A1 (fr) Composés et leurs utilisations
AU2021903584A0 (en) Compounds and uses therefor
HK40123856A (en) Compounds and uses thereof
CA3260518A1 (fr) Agents de modulation d'entrée et leurs utilisations
AU2023901964A0 (en) Agents and Uses Therefor
AU2023900376A0 (en) Biomarkers and uses thereof